{"id":"NCT02528721","sponsor":"Meridian Bioscience, Inc.","briefTitle":"Exalenz Lab Mode System Compared to Biopsy for H.Pylori Detection","officialTitle":"Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the BreathID® Hp Lab System Compared to Biopsy Results","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-10","primaryCompletion":"2016-06","completion":"2016-07","firstPosted":"2015-08-19","resultsPosted":"2017-03-03","lastUpdate":"2022-12-20"},"enrollment":282,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Helicobacter Pylori Infection"],"interventions":[{"type":"DEVICE","name":"Dual Mode BreathID Hp System","otherNames":["Hp™ TWO","Dual Mode BreathID® Hp"]}],"arms":[{"label":"Initial Diagnosis Subjects","type":"EXPERIMENTAL"},{"label":"Post Therapy Subjects","type":"EXPERIMENTAL"}],"summary":"The Exalenz Dual Mode BreathID® Hp System comprised of IDkit: Hp™ TWO and the Dual Mode BreathID® Hp test device will be used to perform a urea breath test in the initial diagnosis and post treatment monitoring of H.pylori infection in adult patients and its results will be compared to biopsy results.","primaryOutcome":{"measure":"Sensitivity is Described as the Accuracy of the Breath Test in Detecting H.Pylori Infection Compared to Biopsy","timeFrame":"9 months","effectByArm":[{"arm":"Initial Diagnosis Subjects","deltaMin":98.32,"sd":null},{"arm":"Post Therapy Subjects","deltaMin":98.53,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":1},"locations":{"siteCount":13,"countries":["United States","Israel"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":203},"commonTop":["Nausea","Cyst","Gastric ulcer","Lightheadedness"]}}